The Brigham and Dana-Farber Board Review and Comprehensive Update in Hematology and Oncology 2022


61 Videos + 2 PDFs
File Size = 8.53 GB
Categories: , ,

More Information About: The Brigham and Dana-Farber Board Review and Comprehensive Update in Hematology and Oncology 2022

Course/Book Format:

61 Videos + 2 PDFs
File Size = 8.53 GB

Course/Book Details (Overview + Topics/Speakers):

The Brigham and Dana-Farber Board Review and Comprehensive Update in Hematology and Oncology is a case-based online CME course focused on improving overall knowledge and clinical competency. Prep for your board exam and stay current on basic principles, changing guidelines and therapeutic strategies. Practice improvement areas featured in the continuing medical education program include:

  • Acquired/Congenital Bone Marrow Failure
  • Thalassemia/Hemoglobinopathies
  • Transfusion Medicine
  • New Therapies (Pharmacology)
  • Infections of the Immunocompromised
  • Hematologic Malignancies (Acute/Chronic Leukemias; Myeloma/Lymphomas)
  • Thoracic Oncology (Head/Neck/Lung/Thyroid)
  • and many more…

Learning Objectives

At the conclusion of this activity, the participant will be able to:

  • Apply current/recommended hematology and oncology guidelines in clinical practice
  • Perform differential diagnosis of complex clinical presentations related to hematologic and oncologic disorders
  • Identify/apply current therapeutic options for specific hematologic and oncologic disorders
  • Review and interpret up-to-date literature relevant to clinical practice in hematology and oncology
  • Demonstrate knowledge of pathophysiology as it applies to management of hematology and oncology disorders
  • Apply knowledge gained to the ABIM certification/recertification hematology and oncology examinations

Intended Audience

The activity was planned for fellows/trainees, practicing hematology and oncology specialists (MDs), and other professional affiliates (internists with an interest in hematology and oncology) who are preparing to take ABIM board review or recertification examinations, or who seek CME activities to improve patient care in the areas of hematology and oncology medicine.


Molecular Genetics of Cancer – Nikhil Wagle, MD

Advances in Cancer Drug Development Part I – Chemotherapy and Targeted Agents – Geoffrey I. Shapiro, MD, PhD

Advances in Cancer Drug Development Part II – Modulation of the Tumor Microenvironment – Geoffrey I. Shapiro, MD, PhD

Infections in Cancer Patients – Lindsey Baden, MD

Symptom Management in Patients with Cancer – Andrew J. Lawton, MD

Communication: The Key to Excellence in End-of-Life Care – Rachelle E. Bernacki, MD, MS, FAAHPM, AGSF

Biology of Hematopoietic Stem Cell Transplantation – Robert J. Soiffer, MD

Biology of Acute Leukemia and Myelodysplastic Syndromes – Benjamin L. Ebert, MD, PhD

Acute Leukemias – Daniel J. DeAngelo, MD, PhD

Myelodysplastic Syndrome – Eric S. Winer, MD

Chronic Myelogenous Leukemia – Marlise R. Luskin, MD

Myeloproliferative Syndromes – Ann M. Mullally, MD

Multiple Myeloma – Kenneth C. Anderson, MD

Waldenstrom Macroglobulemia and Amyloidosis – Jorge J. Castillo, MD

Low Grade Lymphomas – Caron A. Jacobson, MD

Aggressive Non-Hodgkin Lymphoma – Eric D. Jacobsen, MD

Hodgkin’s Lymphoma – Reid W. Merryman, MD

Diagnosis and Treatment of CLL and Related B Cell Malignancies – Matthew S. Davids, MD

Head and Neck Cancer – Robert I. Haddad, MD

Natural History, Screening, and Small Cell Lung Cancer – Bruce E. Johnson, MD

Management of Stage I-III Non Small Cell Lung Cancer – Mark Awad, MD, PhD

Management of Metastatic Non Small Cell Lung Cancer – Mark Awad, MD, PhD

Mesothelioma and Thymoma – David M. Jackman, MD

Carcinoid and Neuroendocrine Tumors – Jennifer Ang Chan, MD

Novel Approaches for the Management of Esophageal and Gastric Cancers – Peter C. Enzinger, MD

Pancreatic Cancer – Brian M. Wolpin, MD

Hepatobiliary Cancer – James M. Cleary, MD, PhD

Anal Cancer & Colorectal Cancers Part 1 – Robert J. Mayer, MD

Colorectal Cancers Part 2 – Robert J. Mayer, MD

Gastrointestinal Cancer: Genetic Syndromes – Matthew Yurgelun, MD

Testicular Cancer – Mark M. Pomerantz, MD

Renal and Bladder Cancer – Guru P. Sonpavde, MBBS

Prostate Cancer Part I: Overview and Management of Localized Disease – Atish D. Choudhury, MD, PhD

Prostate Cancer Part II: Management of Disseminated Prostate Cancer – Atish D. Choudhury, MD, PhD

Melanoma – F. Stephen Hodi, MD

Sarcomas and Gastrointestinal Stromal Tumors (GIST) – Suzanne George, MD

Molecular Advances and Emerging Treatment Strategies in Ovarian Cancer – Ursula A. Matulonis, MD

Cervical and Endometrial Cancer – Panagiotis A. Konstantinopoulos, MD, PhD

Neuro-oncology – David A. Reardon, MD

Breast Cancer – Risk Factors, Genetics, Screening, and Prevention – Judy E. Garber, MD, MPH

Multimodality Therapy for Early Stage Breast Cancer: Part 1 – Surgery and Radiation – Harold J. Burstein, MD, PhD

Multimodality Therapy for Early Stage Breast Cancer: Part 2 – Systemic Therapy – Harold J. Burstein, MD, PhD

Management of Metastatic Breast Cancer – Adrienne G. Waks, MD

Breast Cancer Survivorship – Ann H. Partridge, MD, MPH

Hematopoiesis and Cytokines – David T. Scadden, MD

Acquired Bone Marrow Failure – Julie-Aurore Losman, MD, PhD

Congenital Bone Marrow Failure – Akiko Shimamura, MD, PhD

Hemophagocytic Syndromes and Related Immunodeficiencies – Barbara A. Degar, MD

Anemia – An Overview – Robert Stern, MD

Iron Deficiency and Iron Overload – Mark D. Fleming, MD, PhD

Immune Hemolytic Anemia – Richard M. Kaufman, MD

Non-immune Hemolytic Anemia – David E. Golan, PhD, MD

Sickle Cell Disease – Maureen M. Achebe, MD, MPH

Thalassemia and Other Hemoglobinopathies – Matthew M. Heeney, MD

Disorders of Neutrophils – Nancy Berliner, MD

Acquired Thrombocytopenias – Elisabeth M. Battinelli, MD, PhD

Hemophilia – Aric D. Parnes, MD

Von Willebrand Disease and Congenital Platelet Disorders – Nathan T. Connell, MD, MPH

Congenital and Acquired Thrombophilia – Kenneth A. Bauer, MD

Use of Direct Oral Anticoagulants in Clinical Practice – Jean M. Connors, MD

Transfusion Medicine for the Clinician – Walter H. Dzik, MD

Date of Original Release: June 30, 2022

Target Audience and Covered Specialties:

Hematology, Oakstone, Oncology, simple

Delivery Method and Usage Instructions

After purchasing this product, Downloadable Link of The Brigham and Dana-Farber Board Review and Comprehensive Update in Hematology and Oncology 2022 course/book will be sent to Customer’s Email Address The Download Links Will NOT Expire, Can Be Used Anytime, Can be Downloaded on device for offline usage


General Detail about CME Courses:

CME (Continuing medical education) Lectures helps to maintain competence and learn about new and developing areas of specialty. CME and Board Review Courses are the Best options for knowledge improvement and update. also you can use them to get best performance on your board exam.

  Important Notice  

after buying this product, you will be provided with Download Link to The Brigham and Dana-Farber Board Review and Comprehensive Update in Hematology and Oncology 2022, Download Link DONT HAVE Expiry Time , you can use it anytime. Downloading The content is ALLOWED, you can easily save the product on your device.


NO CME Credits and Accreditation will be issued
By Purchasing This course, you will receive all of the mentioned content as download link.
The Course link will not expire and is lifetime


There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.

Shopping Cart